0001517681
false
2022
Q2
--06-30
P1Y
P1Y
0001517681
2021-07-01
2021-12-31
0001517681
2022-02-14
0001517681
2021-12-31
0001517681
2021-06-30
0001517681
us-gaap:SeriesAPreferredStockMember
2021-12-31
0001517681
us-gaap:SeriesAPreferredStockMember
2021-06-30
0001517681
us-gaap:SeriesBPreferredStockMember
2021-12-31
0001517681
us-gaap:SeriesBPreferredStockMember
2021-06-30
0001517681
2021-10-01
2021-12-31
0001517681
2020-10-01
2020-12-31
0001517681
2020-07-01
2020-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2020-06-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2020-06-30
0001517681
us-gaap:CommonStockMember
2020-06-30
0001517681
PPCB:CommonStockIssuableMember
2020-06-30
0001517681
us-gaap:AdditionalPaidInCapitalMember
2020-06-30
0001517681
PPCB:SubscriptionReceivableMember
2020-06-30
0001517681
us-gaap:RetainedEarningsMember
2020-06-30
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-06-30
0001517681
us-gaap:TreasuryStockMember
2020-06-30
0001517681
2020-06-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2020-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2020-09-30
0001517681
us-gaap:CommonStockMember
2020-09-30
0001517681
PPCB:CommonStockIssuableMember
2020-09-30
0001517681
us-gaap:AdditionalPaidInCapitalMember
2020-09-30
0001517681
PPCB:SubscriptionReceivableMember
2020-09-30
0001517681
us-gaap:RetainedEarningsMember
2020-09-30
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-09-30
0001517681
us-gaap:TreasuryStockMember
2020-09-30
0001517681
2020-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2021-06-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2021-06-30
0001517681
us-gaap:CommonStockMember
2021-06-30
0001517681
PPCB:CommonStockIssuableMember
2021-06-30
0001517681
us-gaap:AdditionalPaidInCapitalMember
2021-06-30
0001517681
PPCB:SubscriptionReceivableMember
2021-06-30
0001517681
us-gaap:RetainedEarningsMember
2021-06-30
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-06-30
0001517681
us-gaap:TreasuryStockMember
2021-06-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2021-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2021-09-30
0001517681
us-gaap:CommonStockMember
2021-09-30
0001517681
PPCB:CommonStockIssuableMember
2021-09-30
0001517681
us-gaap:AdditionalPaidInCapitalMember
2021-09-30
0001517681
PPCB:SubscriptionReceivableMember
2021-09-30
0001517681
us-gaap:RetainedEarningsMember
2021-09-30
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-09-30
0001517681
us-gaap:TreasuryStockMember
2021-09-30
0001517681
2021-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2020-07-01
2020-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2020-07-01
2020-09-30
0001517681
us-gaap:CommonStockMember
2020-07-01
2020-09-30
0001517681
PPCB:CommonStockIssuableMember
2020-07-01
2020-09-30
0001517681
us-gaap:AdditionalPaidInCapitalMember
2020-07-01
2020-09-30
0001517681
PPCB:SubscriptionReceivableMember
2020-07-01
2020-09-30
0001517681
us-gaap:RetainedEarningsMember
2020-07-01
2020-09-30
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-07-01
2020-09-30
0001517681
us-gaap:TreasuryStockMember
2020-07-01
2020-09-30
0001517681
2020-07-01
2020-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2020-10-01
2020-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2020-10-01
2020-12-31
0001517681
us-gaap:CommonStockMember
2020-10-01
2020-12-31
0001517681
PPCB:CommonStockIssuableMember
2020-10-01
2020-12-31
0001517681
us-gaap:AdditionalPaidInCapitalMember
2020-10-01
2020-12-31
0001517681
PPCB:SubscriptionReceivableMember
2020-10-01
2020-12-31
0001517681
us-gaap:RetainedEarningsMember
2020-10-01
2020-12-31
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-10-01
2020-12-31
0001517681
us-gaap:TreasuryStockMember
2020-10-01
2020-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2021-07-01
2021-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2021-07-01
2021-09-30
0001517681
us-gaap:CommonStockMember
2021-07-01
2021-09-30
0001517681
PPCB:CommonStockIssuableMember
2021-07-01
2021-09-30
0001517681
us-gaap:AdditionalPaidInCapitalMember
2021-07-01
2021-09-30
0001517681
PPCB:SubscriptionReceivableMember
2021-07-01
2021-09-30
0001517681
us-gaap:RetainedEarningsMember
2021-07-01
2021-09-30
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-07-01
2021-09-30
0001517681
us-gaap:TreasuryStockMember
2021-07-01
2021-09-30
0001517681
2021-07-01
2021-09-30
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2021-10-01
2021-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2021-10-01
2021-12-31
0001517681
us-gaap:CommonStockMember
2021-10-01
2021-12-31
0001517681
PPCB:CommonStockIssuableMember
2021-10-01
2021-12-31
0001517681
us-gaap:AdditionalPaidInCapitalMember
2021-10-01
2021-12-31
0001517681
PPCB:SubscriptionReceivableMember
2021-10-01
2021-12-31
0001517681
us-gaap:RetainedEarningsMember
2021-10-01
2021-12-31
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-10-01
2021-12-31
0001517681
us-gaap:TreasuryStockMember
2021-10-01
2021-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2020-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2020-12-31
0001517681
us-gaap:CommonStockMember
2020-12-31
0001517681
PPCB:CommonStockIssuableMember
2020-12-31
0001517681
us-gaap:AdditionalPaidInCapitalMember
2020-12-31
0001517681
PPCB:SubscriptionReceivableMember
2020-12-31
0001517681
us-gaap:RetainedEarningsMember
2020-12-31
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-12-31
0001517681
us-gaap:TreasuryStockMember
2020-12-31
0001517681
2020-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesAPreferredStockMember
2021-12-31
0001517681
us-gaap:PreferredStockMember
us-gaap:SeriesBPreferredStockMember
2021-12-31
0001517681
us-gaap:CommonStockMember
2021-12-31
0001517681
PPCB:CommonStockIssuableMember
2021-12-31
0001517681
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0001517681
PPCB:SubscriptionReceivableMember
2021-12-31
0001517681
us-gaap:RetainedEarningsMember
2021-12-31
0001517681
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31
0001517681
us-gaap:TreasuryStockMember
2021-12-31
0001517681
2020-11-16
2020-11-17
0001517681
PPCB:IntercompanyLoansMember
2021-07-01
2021-12-31
0001517681
PPCB:IntercompanyLoansMember
2020-07-01
2020-12-31
0001517681
PPCB:TwoThousandAndTwentyOneSecuritiesPurchaseAgreementMember
2021-12-31
0001517681
srt:WeightedAverageMember
2021-12-31
0001517681
srt:WeightedAverageMember
2021-06-30
0001517681
us-gaap:MachineryAndEquipmentMember
2021-07-01
2021-12-31
0001517681
us-gaap:FurnitureAndFixturesMember
2021-07-01
2021-12-31
0001517681
us-gaap:EmployeeStockOptionMember
2021-07-01
2021-12-31
0001517681
us-gaap:EmployeeStockOptionMember
2020-07-01
2020-12-31
0001517681
us-gaap:WarrantMember
2021-07-01
2021-12-31
0001517681
us-gaap:WarrantMember
2020-07-01
2020-12-31
0001517681
PPCB:UnvestedRestrictedStockMember
2021-07-01
2021-12-31
0001517681
PPCB:UnvestedRestrictedStockMember
2020-07-01
2020-12-31
0001517681
us-gaap:ConvertibleDebtSecuritiesMember
2021-07-01
2021-12-31
0001517681
us-gaap:ConvertibleDebtSecuritiesMember
2020-07-01
2020-12-31
0001517681
PPCB:DirectorsAndOfficerMember
2021-12-31
0001517681
PPCB:DirectorsAndOfficerMember
2021-06-30
0001517681
2017-08-10
0001517681
2017-08-09
2017-08-10
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
2017-08-10
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
2017-08-07
2017-08-10
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
2018-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
PPCB:ConsultantMember
2018-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
PPCB:ConsultantMember
2019-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
2019-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
2019-07-01
2020-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
2020-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
PPCB:SettlementAndMutualReleaseAgreementMember
2021-03-15
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
PPCB:SettlementAndMutualReleaseAgreementMember
2020-07-01
2021-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
PPCB:SettlementAndMutualReleaseAgreementMember
2021-06-30
0001517681
PPCB:AugustTenTwoThousandAndSeventeenConsultingAgreementMember
PPCB:SettlementAndMutualReleaseAgreementMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2019-08-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2019-09-04
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2019-09-03
2019-09-04
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2019-08-29
2019-08-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
PPCB:FirstWarrantMember
2019-08-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
PPCB:SecondWarrantMember
2019-08-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
PPCB:ThirdWarrantMember
2019-08-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2019-07-01
2020-06-30
0001517681
PPCB:AuctusFinancingAgreementMember
2020-06-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2020-06-30
0001517681
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2020-06-30
0001517681
PPCB:AuctusFinancingAgreementMember
2021-06-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2021-06-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2020-07-01
2021-06-30
0001517681
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2021-06-30
0001517681
PPCB:AuctusFinancingAgreementMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2021-07-01
2021-12-31
0001517681
PPCB:AuctusFundLLCMember
PPCB:AugustTwoThousandNineteenAuctusNoteMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
2019-10-03
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
2019-10-01
2019-10-03
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
srt:MinimumMember
2019-10-01
2019-10-03
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
srt:MaximumMember
2019-10-01
2019-10-03
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
2020-06-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
2019-07-01
2020-06-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
2020-09-15
2020-09-16
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
2020-11-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
2021-06-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:CrownBridgePartnersLLCMember
PPCB:OctoberThreeTwoThousandNineteenAuctusNoteMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:GWHoldingsGroupLLCMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
2020-12-10
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:GWHoldingsGroupLLCMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
2020-12-09
2020-12-10
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:GWHoldingsGroupLLCMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
srt:MinimumMember
2020-12-09
2020-12-10
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:GWHoldingsGroupLLCMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
srt:MaximumMember
2020-12-09
2020-12-10
0001517681
PPCB:GWHoldingsFinancingAgreementMember
PPCB:GWHoldingsGroupLLCMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
2020-12-10
0001517681
PPCB:GWHoldingsFinancingAgreementMember
PPCB:GWHoldingsGroupLLCMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
2021-06-30
0001517681
PPCB:GWHoldingsFinancingAgreementMember
PPCB:GWHoldingsGroupLLCMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
2021-12-31
0001517681
PPCB:GWHoldingsFinancingAgreementMember
PPCB:DecemberTenTwoThousandTwentyGWNoteMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:JanuaryFiveTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-01-05
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-03-16
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:MarchSixteenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-03-15
2021-03-16
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AugustNineteenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-08-19
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:AugustNineteenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-08-18
2021-08-19
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-09-22
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-09-21
2021-09-22
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MinimumMember
2021-09-21
2021-09-22
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MaximumMember
2021-09-21
2021-09-22
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MinimumMember
2021-09-21
2021-09-22
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-09-22
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-07-01
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-09-21
2021-09-22
0001517681
PPCB:GenevaRothFinancingAgreementAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-06-30
0001517681
PPCB:GenevaRothFinancingAgreementAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
2021-06-30
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
2021-06-30
0001517681
PPCB:GenevaRothFinancingAgreementAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-12-31
0001517681
PPCB:GenevaRothFinancingAgreementAgreementMember
PPCB:SeptemberTwentyTwoTwoThousandTwentyGenevaRothMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:OctoberTwentyOneTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-10-21
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:OctoberTwentyOneTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-10-20
2021-10-21
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:NovemberTwentySixTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-11-26
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:NovemberTwentySixTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-11-25
2021-11-26
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:NovemberTwentySixTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MinimumMember
2021-11-25
2021-11-26
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:NovemberTwentySixTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MaximumMember
2021-11-25
2021-11-26
0001517681
PPCB:GenevaRothFinancingAgreementAgreementMember
PPCB:NovemberTwentySixTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:DecemberSevenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-12-07
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:DecemberSevenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-12-06
2021-12-07
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:DecemberSevenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MinimumMember
2021-12-06
2021-12-07
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:DecemberSevenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MaximumMember
2021-12-06
2021-12-07
0001517681
PPCB:SecuritiesPurchaseAgreementMember
PPCB:DecemberSevenThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
srt:MinimumMember
2021-12-06
2021-12-07
0001517681
PPCB:GenevaRothFinancingAgreementAgreementMember
PPCB:DecemberSevenTwoThousandTwentyOneGenevaRothMember
PPCB:GenevaRothRemarkHoldingsIncMember
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
2021-07-01
2021-12-31
0001517681
PPCB:SecuritiesPurchaseAgreementMember
2020-07-01
2020-12-31
0001517681
2020-02-03
0001517681
2020-02-04
0001517681
us-gaap:PreferredStockMember
2021-12-31
0001517681
srt:MaximumMember
us-gaap:SeriesBPreferredStockMember
2021-12-31
0001517681
us-gaap:SeriesBPreferredStockMember
PPCB:NathanielszMember
2021-12-31
0001517681
us-gaap:SeriesBPreferredStockMember
2021-07-01
2021-12-31
0001517681
us-gaap:SeriesAPreferredStockMember
2021-07-01
2021-12-31
0001517681
us-gaap:SeriesAPreferredStockMember
2020-07-01
2021-06-30
0001517681
us-gaap:SeriesBPreferredStockMember
2020-07-01
2021-06-30
0001517681
srt:MaximumMember
PPCB:DutchessMember
PPCB:CommonStockPurchaseAgreementMember
2021-11-28
2021-11-30
0001517681
PPCB:DutchessMember
PPCB:CommonStockPurchaseAgreementMember
2021-11-28
2021-11-30
0001517681
PPCB:DutchessMember
PPCB:CommonStockPurchaseAgreementMember
2021-11-30
0001517681
PPCB:DutchessMember
PPCB:CommonStockPurchaseAgreementMember
us-gaap:RestrictedStockMember
2021-11-28
2021-11-30
0001517681
PPCB:DutchessMember
PPCB:CommonStockPurchaseAgreementMember
us-gaap:RestrictedStockMember
2021-11-30
0001517681
PPCB:DutchessMember
PPCB:CommonStockPurchaseAgreementMember
2021-12-31
0001517681
us-gaap:ConvertibleDebtMember
2021-07-01
2021-12-31
0001517681
us-gaap:ConvertibleDebtMember
2021-12-31
0001517681
us-gaap:ConvertibleDebtMember
srt:MinimumMember
2021-12-31
0001517681
us-gaap:ConvertibleDebtMember
srt:MaximumMember
2021-12-31
0001517681
PPCB:UnderlyingFinancingAgreementsMember
us-gaap:ConvertibleDebtMember
us-gaap:CommonStockMember
2021-12-31
0001517681
us-gaap:CommonStockMember
2021-08-11
2021-08-12
0001517681
us-gaap:CommonStockMember
2021-08-12
0001517681
us-gaap:CommonStockMember
2021-07-01
2021-12-31
0001517681
PPCB:LegalServicesMember
us-gaap:CommonStockMember
2021-08-11
2021-08-12
0001517681
PPCB:LegalServicesMember
us-gaap:CommonStockMember
2021-08-12
0001517681
PPCB:LegalServicesMember
us-gaap:CommonStockMember
2021-07-01
2021-12-31
0001517681
PPCB:ConsultantServicesMember
us-gaap:CommonStockMember
2021-09-29
2021-09-30
0001517681
PPCB:ConsultantServicesMember
us-gaap:CommonStockMember
2021-09-30
0001517681
PPCB:ConsultantServicesMember
2021-07-01
2021-12-31
0001517681
PPCB:NathanielszCancellationAgreementMember
2021-08-11
2021-08-12
0001517681
PPCB:MrNathanielszMember
PPCB:NathanielszCancellationAgreementMember
2021-07-19
2021-07-20
0001517681
PPCB:MrNathanielszMember
PPCB:NathanielszCancellationAgreementMember
2021-08-11
2021-08-12
0001517681
PPCB:MrNathanielszMember
PPCB:NathanielszCancellationAgreementMember
2021-08-12
0001517681
PPCB:MrNathanielszMember
2021-07-01
2021-12-31
0001517681
PPCB:DeferredSalaryMember
PPCB:CancellationAgreementMember
PPCB:ChiefScientificOfficerandDirectorMember
2021-08-12
0001517681
PPCB:ChiefScientificOfficerandDirectorMember
2021-08-11
2021-08-12
0001517681
PPCB:ChiefScientificOfficerandDirectorMember
2021-08-12
0001517681
PPCB:ChiefScientificOfficerandDirectorMember
2021-07-01
2021-12-31
0001517681
PPCB:DirectorAgreementMember
PPCB:JosefZelingerMember
2021-08-12
0001517681
PPCB:DirectorAgreementMember
PPCB:JosefZelingerMember
2020-07-01
2021-06-30
0001517681
PPCB:DirectorAgreementMember
PPCB:JosefZelingerMember
2021-06-30
0001517681
PPCB:DirectorAgreementMember
PPCB:JosefZelingerMember
2021-07-01
2021-12-31
0001517681
us-gaap:WarrantMember
2021-07-09
2021-09-27
0001517681
us-gaap:WarrantMember
2021-09-27
0001517681
PPCB:SeriesBWarrantMember
2021-09-27
0001517681
us-gaap:CommonStockMember
2021-09-27
0001517681
us-gaap:CommonStockMember
2021-10-31
0001517681
us-gaap:WarrantMember
2021-10-31
0001517681
PPCB:SeriesBWarrantMember
2021-12-31
0001517681
PPCB:FourtyFourSeriesAWarrantsMember
2021-12-31
0001517681
PPCB:FourtyFourSeriesAWarrantsMember
2021-07-01
2021-12-31
0001517681
PPCB:From2012ThroughThe2014Member
2021-07-01
2021-12-31
0001517681
us-gaap:RoyaltyAgreementTermsMember
2012-06-01
2012-06-30
0001517681
us-gaap:LicenseAgreementTermsMember
2012-06-01
2012-06-30
0001517681
PPCB:ConsultingAgreementMember
2021-09-28
2021-10-02
0001517681
PPCB:OneYearCollaborationAgreementMember
2018-09-10
2018-09-13
0001517681
PPCB:TwoYearCollaborationAgreementMember
2018-09-10
2018-09-13
0001517681
PPCB:TwoYearCollaborationAgreementMember
2018-07-01
2019-06-30
0001517681
PPCB:TwoYearCollaborationAgreementMember
2020-07-01
2021-06-30
0001517681
PPCB:TwoYearCollaborationAgreementMember
2020-09-29
2020-10-02
0001517681
PPCB:TwoYearCollaborationAgreementMember
2020-11-01
2020-11-30
0001517681
PPCB:TwoYearCollaborationAgreementMember
2021-03-01
2021-03-31
0001517681
PPCB:TwoYearCollaborationAgreementMember
2021-12-01
2021-12-31
0001517681
us-gaap:SubsequentEventMember
PPCB:TwoYearCollaborationAgreementMember
2022-09-01
2022-09-30
0001517681
PPCB:TwoYearCollaborationAgreementMember
PPCB:UniversityOfJaenMember
2020-09-29
2020-10-02
0001517681
PPCB:FormerDirectorMember
2021-12-31
0001517681
PPCB:FormerDirectorMember
2021-06-30
0001517681
PPCB:FormerDirectorMember
2020-06-30
0001517681
PPCB:NorthHorizonPtyLtdMember
2021-05-03
2021-05-06
0001517681
PPCB:NorthHorizonPtyLtdMember
2021-05-05
2021-05-06
0001517681
PPCB:NorthHorizonPtyLtdMember
2021-10-01
2021-12-31
0001517681
PPCB:NorthHorizonPtyLtdMember
2020-10-01
2020-12-31
0001517681
PPCB:NorthHorizonPtyLtdMember
2020-07-01
2021-12-31
0001517681
PPCB:NorthHorizonPtyLtdMember
2019-07-01
2020-12-31
0001517681
PPCB:NathanielszEmploymentAgreementMember
2015-02-24
2015-02-25
0001517681
PPCB:NathanielszEmploymentAgreementMember
2021-07-01
2021-12-31
0001517681
PPCB:NathanielszEmploymentAgreementMember
2020-07-01
2021-06-30
0001517681
PPCB:NathanielszEmploymentAgreementMember
srt:MinimumMember
2018-03-15
2018-03-16
0001517681
PPCB:NathanielszEmploymentAgreementMember
srt:MaximumMember
2018-03-15
2018-03-16
0001517681
PPCB:MrsNathanielszMember
2018-01-28
2018-02-01
0001517681
PPCB:JamesNathanielszMember
2016-02-24
2016-02-25
0001517681
PPCB:MrsNathanielszMember
2021-07-01
2021-12-31
0001517681
PPCB:MrNathanielszMember
PPCB:BoardOfDirectorsMember
2019-05-13
2019-05-14
0001517681
srt:ChiefExecutiveOfficerMember
2018-07-01
2019-06-30
0001517681
srt:ChiefExecutiveOfficerMember
2020-07-01
2021-06-30
0001517681
PPCB:BoardOfDirectorsMember
PPCB:MrNathanielszMember
2021-08-11
2021-08-12
0001517681
srt:ChiefExecutiveOfficerMember
2021-07-01
2021-12-31
0001517681
PPCB:EmploymentAgreementMember
PPCB:MrNathanielszMember
2019-05-13
2019-05-14
0001517681
PPCB:EmploymentAgreementMember
PPCB:RestrictedStocksUnitsRSUMember
2019-05-13
2019-05-14
0001517681
PPCB:EmploymentAgreementMember
PPCB:AdditionaNathanielszRSUsMember
2019-05-13
2019-05-14
0001517681
PPCB:EmploymentAgreementMember
PPCB:AdditionaNathanielszRSUsMember
2021-07-01
2021-12-31
0001517681
PPCB:ServicesAgreementMember
PPCB:DrKenyonMember
2019-05-13
2019-05-14
0001517681
PPCB:ServicesAgreementMember
PPCB:DrKenyonMemberMember
2019-05-13
2019-05-14
0001517681
PPCB:ServicesAgreementMember
PPCB:InitialKenyonRSUsMember
2019-05-13
2019-05-14
0001517681
PPCB:ServicesAgreementMember
PPCB:AdditionalKenyonRSUsMember
2019-05-13
2019-05-14
0001517681
PPCB:ServicesAgreementMember
2019-05-14
0001517681
PPCB:ServicesAgreementMember
us-gaap:RestrictedStockUnitsRSUMember
2021-07-01
2021-12-31
0001517681
PPCB:ServicesAgreementMember
PPCB:DrKenyonMember
2021-08-12
0001517681
PPCB:ServicesAgreementMember
PPCB:DrKenyonMember
2021-08-11
2021-08-12
0001517681
PPCB:LenderOneMember
2021-07-01
2021-12-31
0001517681
PPCB:LenderTwoMember
2021-07-01
2021-12-31
0001517681
PPCB:LenderThreeMember
2021-07-01
2021-12-31
0001517681
PPCB:LenderOneMember
2021-12-31
0001517681
PPCB:LenderTwoMember
2021-12-31
0001517681
PPCB:LenderThreeMember
2021-12-31
0001517681
PPCB:LenderOneMember
2020-07-01
2020-12-31
0001517681
PPCB:LenderTwoMember
2020-07-01
2020-12-31
0001517681
PPCB:LenderOneMember
2020-12-31
0001517681
PPCB:LenderTwoMember
2020-12-31
0001517681
2020-07-01
2021-06-30
0001517681
us-gaap:ConvertibleDebtMember
2021-06-30
0001517681
us-gaap:MeasurementInputPriceVolatilityMember
us-gaap:DerivativeMember
2021-12-31
0001517681
us-gaap:MeasurementInputPriceVolatilityMember
2021-12-31
0001517681
us-gaap:MeasurementInputExpectedTermMember
us-gaap:DerivativeMember
2021-07-01
2021-12-31
0001517681
us-gaap:MeasurementInputExpectedTermMember
2021-07-01
2021-12-31
0001517681
us-gaap:MeasurementInputRiskFreeInterestRateMember
us-gaap:DerivativeMember
2021-12-31
0001517681
us-gaap:MeasurementInputRiskFreeInterestRateMember
2021-12-31
0001517681
us-gaap:MeasurementInputExpectedDividendRateMember
us-gaap:DerivativeMember
2021-12-31
0001517681
us-gaap:MeasurementInputExpectedDividendRateMember
2021-12-31
0001517681
us-gaap:FairValueInputsLevel1Member
2021-12-31
0001517681
us-gaap:FairValueInputsLevel2Member
2021-12-31
0001517681
us-gaap:FairValueInputsLevel3Member
2021-12-31
0001517681
us-gaap:FairValueInputsLevel1Member
2021-06-30
0001517681
us-gaap:FairValueInputsLevel2Member
2021-06-30
0001517681
us-gaap:FairValueInputsLevel3Member
2021-06-30
0001517681
us-gaap:SubsequentEventMember
2022-01-01
2022-01-31
0001517681
us-gaap:SubsequentEventMember
2022-01-31
0001517681
us-gaap:SubsequentEventMember
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SixthStreetLendingLLCMember
PPCB:JanuaryFourTwoThousandAndTwentyTwoSixthStreetMember
2022-01-04
0001517681
us-gaap:SubsequentEventMember
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SixthStreetLendingLLCMember
PPCB:JanuaryFourTwoThousandAndTwentyTwoSixthStreetMember
2022-01-02
2022-01-04
0001517681
us-gaap:SubsequentEventMember
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SixthStreetLendingLLCMember
PPCB:JanuaryFourTwoThousandAndTwentyTwoSixthStreetMember
srt:MinimumMember
2022-01-03
2022-01-04
0001517681
us-gaap:SubsequentEventMember
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SixthStreetLendingLLCMember
PPCB:JanuaryFourTwoThousandAndTwentyTwoSixthStreetMember
srt:MaximumMember
2022-01-03
2022-01-04
0001517681
us-gaap:SubsequentEventMember
PPCB:SecuritiesPurchaseAgreementMember
PPCB:SixthStreetLendingLLCMember
PPCB:JanuaryFourTwoThousandAndTwentyTwoSixthStreetMember
2022-01-03
2022-01-04
0001517681
us-gaap:SubsequentEventMember
PPCB:FourteenSeriesAWarrantsMember
us-gaap:WarrantMember
2022-01-01
2022-01-31
0001517681
us-gaap:SubsequentEventMember
us-gaap:WarrantMember
2022-01-01
2022-01-31
0001517681
us-gaap:SubsequentEventMember
PPCB:SeriesBWarrantsMember
2022-01-31
0001517681
us-gaap:SubsequentEventMember
us-gaap:CommonStockMember
2022-01-31
0001517681
us-gaap:SubsequentEventMember
PPCB:LegalServicesMember
2022-01-18
2022-01-20
0001517681
us-gaap:SubsequentEventMember
PPCB:LegalServicesMember
2022-01-20
0001517681
us-gaap:SubsequentEventMember
PPCB:ConsultantServicesMember
2022-01-22
2022-01-24
0001517681
us-gaap:SubsequentEventMember
PPCB:ConsultantServicesMember
2022-01-24
0001517681
PPCB:ConsultantServicesMember
2021-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
PPCB:Integer
iso4217:EUR
iso4217:AUD
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
10-Q
(Mark
One)
☒ |
QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended December 31, 2021
or
☐ |
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the transition period from ___________ to ___________
Commission
File Number: 000-54878
PROPANC
BIOPHARMA, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
33-0662986 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(I.R.S.
Employer
Identification
No.) |
302,
6 Butler Street
Camberwell,
VIC, 3124 Australia
(Address
of principal executive offices) (Zip Code)
61
03 9882 6723
(Registrant’s
telephone number, including area code)
n/a
(Former
name, former address and former fiscal year, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
None |
|
None |
|
None |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer |
☐ |
Accelerated
filer |
☐ |
Non-accelerated
filer |
☒ |
Smaller
reporting company |
☒ |
|
|
Emerging
growth company |
☐ |
If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As
of February 14, 2022, there were 61,417,527 shares of the registrant’s common stock, $0.001 par value per share, issued and outstanding.
PROPANC
BIOPHARMA INC.
Table
of Contents
This
Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act
of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements
regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations,
are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,”
“anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking
statements. We have based these forward-looking statements largely on our current expectations and projections about future events and
trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business
operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and
assumptions. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not
possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which
any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements
we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report
on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking
statements. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements,
except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking
statements.
Unless
expressly indicated or the context requires otherwise, the terms “Propanc,” “company,” “we,” “us,”
and “our” in this document refer to Propanc Biopharma, Inc., a Delaware corporation, and, where appropriate, its wholly owned
subsidiary.
PART
I — FINANCIAL INFORMATION
Item
1. Financial Statements.
The
following unaudited interim condensed consolidated financial statements of Propanc Biopharma, Inc. are included in this Quarterly Report
on Form 10-Q:
INDEX
TO FINANCIAL STATEMENTS
PROPANC
BIOPHARMA, INC. AND SUBSIDIARY
CONDENSED
CONSOLIDATED BALANCE SHEETS
| |
December
31, 2021 | | |
June
30, 2021 | |
| |
(Unaudited) | | |
| |
ASSETS | |
| | | |
| | |
| |
| | | |
| | |
CURRENT
ASSETS: | |
| | | |
| | |
Cash | |
$ | 73,616 | | |
$ | 2,255 | |
GST
tax receivable | |
| 5,625 | | |
| 4,341 | |
Prepaid
expenses and other current assets | |
| 5,637 | | |
| - | |
| |
| | | |
| | |
TOTAL
CURRENT ASSETS | |
| 84,878 | | |
| 6,596 | |
| |
| | | |
| | |
Deferred
offering costs | |
| 20,000 | | |
| - | |
Security
deposit - related party | |
| 2,181 | | |
| 2,250 | |
Property
and equipment, net | |
| 3,118 | | |
| 4,255 | |
| |
| | | |
| | |
TOTAL
ASSETS | |
$ | 110,177 | | |
$ | 13,101 | |
| |
| | | |
| | |
LIABILITIES
AND STOCKHOLDERS’ DEFICIT | |
| | | |
| | |
| |
| | | |
| | |
CURRENT
LIABILITIES: | |
| | | |
| | |
Accounts
payable | |
$ | 920,692 | | |
$ | 1,002,335 | |
Accrued
expenses and other payables | |
| 420,257 | | |
| 892,151 | |
Convertible
notes and related accrued interest, net of discounts and premiums | |
| 972,670 | | |
| 624,583 | |
Embedded
conversion option liabilities | |
| 221,977 | | |
| 54,220 | |
Due
to former director - related party | |
| 32,329 | | |
| 33,347 | |
Loan
from former director - related party | |
| 53,805 | | |
| 55,500 | |
Employee
benefit liability | |
| 418,640 | | |
| 418,538 | |
| |
| | | |
| | |
TOTAL
CURRENT LIABILITIES | |
| 3,040,370 | | |
| 3,080,674 | |
| |
| | | |
| | |
TOTAL
LIABILITIES | |
$ | 3,040,370 | | |
$ | 3,080,674 | |
| |
| | | |
| | |
Commitments
and Contingencies (See Note 8) | |
| - | | |
| | |
| |
| | | |
| | |
STOCKHOLDERS’
DEFICIT: | |
| | | |
| | |
Preferred
stock, 1,500,005 shares authorized, $0.01 par value: | |
| | | |
| | |
Series
A preferred stock, $0.01 par value; 500,000 shares authorized; 500,000 shares issued and outstanding as of December 31, 2021 and
June 30, 2021 | |
$ | 5,000 | | |
$ | 5,000 | |
Series
B preferred stock, $0.01 par value; 5 shares authorized; 1 share issued and outstanding as of December 31, 2021 and June 30, 2021 | |
| - | | |
| - | |
Common
stock, $0.001 par value; 1,000,000,000 shares authorized;53,062,209 and 14,055,393 shares issued and outstanding as of December 31,
2021 and June 30, 2021, respectively | |
| 53,062 | | |
| 14,056 | |
Common
stock issuable (59 shares as of December 31, 2021 and June 30, 2021) | |
| - | | |
| - | |
Additional
paid-in capital | |
| 55,614,865 | | |
| 54,074,110 | |
Accumulated
other comprehensive income | |
| 1,141,700 | | |
| 1,085,204 | |
Accumulated
deficit | |
| (59,698,343 | ) | |
| (58,199,466 | ) |
Treasury
stock (1 share) | |
| (46,477 | ) | |
| (46,477 | ) |
| |
| | | |
| | |
TOTAL
STOCKHOLDERS’ DEFICIT | |
| (2,930,193 | ) | |
| (3,067,573 | ) |
| |
| | | |
| | |
TOTAL
LIABILITIES AND STOCKHOLDERS’ DEFICIT | |
$ | 110,177 | | |
$ | 13,101 | |
The
accompanying unaudited condensed notes are an integral part of these unaudited condensed consolidated financial statements.
PROPANC
BIOPHARMA, INC. AND SUBSIDIARY
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(Unaudited)
| |
2021 | | |
2020 | | |
2021 | | |
2020 | |
| |
Three
Months Ended December 31, | | |
Six
Months Ended December 31, | |
| |
2021 | | |
2020 | | |
2021 | | |
2020 | |
| |
| | |
| | |
| | |
| |
REVENUE | |
| | | |
| | | |
| | | |
| | |
Revenue | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
| |
| | | |
| | | |
| | | |
| | |
OPERATING
EXPENSES | |
| | | |
| | | |
| | | |
| | |
Administration
expenses | |
| 346,164 | | |
| 216,179 | | |
| 777,904 | | |
| 539,290 | |
Occupancy
expenses | |
| 6,550 | | |
| 7,750 | | |
| 14,286 | | |
| 16,954 | |
Research
and development | |
| 50,753 | | |
| 50,165 | | |
| 97,307 | | |
| 101,011 | |
TOTAL
OPERATING EXPENSES | |
| 403,467 | | |
| 274,094 | | |
| 889,497 | | |
| 657,255 | |
| |
| | | |
| | | |
| | | |
| | |
LOSS
FROM OPERATIONS | |
| (403,467 | ) | |
| (274,094 | ) | |
| (889,497 | ) | |
| (657,255 | ) |
| |
| | | |
| | | |
| | | |
| | |
OTHER
INCOME (EXPENSE) | |
| | | |
| | | |
| | | |
| | |
Interest
expense | |
| (177,905 | ) | |
| (157,835 | ) | |
| (287,758 | ) | |
| (317,116 | ) |
Interest
income | |
| - | | |
| 1 | | |
| - | | |
| 1 | |
Change
in fair value of derivative liabilities | |
| (163,853 | ) | |
| (16,950 | ) | |
| (167,757 | ) | |
| 48,002 | |
Gain
on extinguishment of debt, net | |
| - | | |
| - | | |
| - | | |
| 49,985 | |
Foreign
currency transaction gain (loss) | |
| (110,215 | ) | |
| 45,235 | | |
| (1,086 | ) | |
| 47,195 | |
TOTAL
OTHER EXPENSE, NET | |
| (451,973 | ) | |
| (129,549 | ) | |
| (456,601 | ) | |
| (171,933 | ) |
| |
| | | |
| | | |
| | | |
| | |
LOSS
BEFORE TAXES | |
| (855,440 | ) | |
| (403,643 | ) | |
| (1,346,098 | ) | |
| (829,188 | ) |
| |
| | | |
| | | |
| | | |
| | |
Tax
benefit | |
| 55,463 | | |
| - | | |
| 55,463 | | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
NET
LOSS | |
$ | (799,977 | ) | |
$ | (403,643 | ) | |
$ | (1,290,635 | ) | |
$ | (829,188 | ) |
| |
| | | |
| | | |
| | | |
| | |
Deemed
Dividend | |
| (93,398 | ) | |
| - | | |
| (208,242 | ) | |
| - | |
| |
| | | |
| | | |
| | | |
| | |
NET
LOSS AVAILABLE TO COMMON STOCKHOLDERS | |
$ | (893,375 | ) | |
$ | (403,643 | ) | |
$ | (1,498,877 | ) | |
$ | (829,188 | ) |
| |
| | | |
| | | |
| | | |
| | |
BASIC
AND DILUTED NET LOSS PER SHARE | |
$ | (0.02 | ) | |
$ | (0.45 | ) | |
$ | (0.04 | ) | |
$ | (1.13 | ) |
| |
| | | |
| | | |
| | | |
| | |
BASIC
AND DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING | |
| 49,373,565 | | |
| 900,626 | | |
| 38,318,783 | | |
| 735,289 | |
| |
| | | |
| | | |
| | | |
| | |
NET
LOSS AVAILABLE TO COMMON STOCKHOLDERS | |
$ | (893,375 | ) | |
$ | (403,643 | ) | |
$ | (1,498,877 | ) | |
$ | (829,188 | ) |
| |
| | | |
| | | |
| | | |
| | |
OTHER
COMPREHENSIVE INCOME (LOSS) | |
| | | |
| | | |
| | | |
| | |
Unrealized
foreign currency translation gain (loss) | |
| (7,697 | ) | |
| (167,765 | ) | |
| 56,496 | | |
| (243,520 | ) |
| |
| | | |
| | | |
| | | |
| | |
TOTAL
OTHER COMPREHENSIVE INCOME (LOSS) | |
| (7,697 | ) | |
| (167,765 | ) | |
| 56,496 | | |
| (243,520 | ) |
| |
| | | |
| | | |
| | | |
| | |
TOTAL
COMPREHENSIVE LOSS | |
$ | (901,072 | ) | |
$ | (571,408 | ) | |
$ | (1,442,381 | ) | |
$ | (1,072,708 | ) |
The
accompanying unaudited condensed notes are an integral part of these unaudited condensed consolidated financial statements.
PROPANC
BIOPHARMA, INC. AND SUBSIDIARY
CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2021 AND 2020
(Unaudited)
| |
No.
of Shares | | |
Value | | |
No.
of Shares | | |
Value | | |
No.
of Shares | | |
Value | |
| |
No.
of Shares | | |
Value | | |
Paid-in
Capital | | |
Subscription
Receivable | | |
Accumulated
Deficit | | |
| |
Comprehensive
Income | | |
| |
Treasury
Stock | | |
Stockholders’
Deficit | |
| |
Preferred
Stock | | |
| | |
| |
| |
| | |
| | |
| | |
| | |
| | |
| |
| | |
| |
| | |
| |
| |
Series
A | | |
Series
B | | |
Common
Stock | |
| |
Common
Stock Issuable | | |
Additional | | |
| | |
| | |
| |
Accumulated
Other | | |
| |
| | |
Total
| |
| |
No.
of Shares | | |
Value | | |
No.
of Shares | | |
Value | | |
No.
of Shares | | |
Value | |
| |
No.
of Shares | | |
Value | | |
Paid-in
Capital | | |
Subscription
Receivable | | |
Accumulated
Deficit | | |
| |
Comprehensive
Income | | |
| |
Treasury
Stock | | |
Stockholders’
Deficit | |
| |
| | |
| | |
| | |
| | |
| | |
| |
| |
| | |
| | |
| | |
| | |
| | |
| |
| | |
| |
| | |
| |
| |
| | |
| | |
| | |
| | |
| | |
| |
| |
| | |
| | |
| | |
| | |
| | |
| |
| | |
| |
| | |
| |
Balance
at June 30, 2020 | |
| 500,000 | | |
$ | 5,000 | | |
| 1 | | |
$ | - | | |
| 258,120 | | |
$ | 258 | |
| |
| - | | |
$ | - | | |
$ | 50,913,893 | | |
$ | - | | |
$ | (55,781,770 | ) | |
| |
$ | 1,267,671 | | |
| |
$ | (46,477 | ) | |
$ | (3,641,425 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for conversion of convertible debt and accrued interest | |
| - | | |
| - | | |
| - | | |
| - | | |
| 442,031 | | |
| 442 | |
| |
| - | | |
| - | | |
| 480,133 | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| 480,575 | |
Issuance of common stock for services and accrued expenses | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for services and accrued expenses , shares | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Reversal
of common stock issuable due to cancellation of conversions of convertible debt and accrued interest , shares | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Reversal
of put premium upon cancellation of conversions of convertible debt | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for alternate cashless exercise of warrants | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for alternate cashless exercise of warrants, shares | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Reclassification
of put premium upon debt conversion | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| - | | |
| - | | |
| 204,919 | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| 204,919 | |
Issuance
of common stock for cashless exercise of warrants | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for cashless exercise of warrants, shares | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Stock
based compensation in connection with stock option grants | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for deferred offering cost | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for deferred offering cost, shares | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for exercise of warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| 15,445 | | |
| 15 | |
| |
| - | | |
| - | | |
| 201,029 | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| 201,044 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Stock
based compensation in connection with fair value of warrants issued for services | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| - | | |
| - | | |
| 20,718 | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| 20,718 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Vested
restricted stock units | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Vested
restricted stock units, shares | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Foreign
currency translation gain | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| |
| (75,755 | ) | |
| |
| - | | |
| (75,755 | ) |
Fractional
difference due to the reverse stock-split | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Fractional
difference due to the reverse stock-split, shares | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Deemed
dividend upon alternate cashless exercise of warrants | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Net
loss for the three months ended September 31, 2020 | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| - | | |
| - | | |
| - | | |
| - | | |
| (425,545 | ) | |
| |
| - | | |
| |
| - | | |
| (425,545 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Balance
at September 30, 2020 | |
| 500,000 | | |
$ | 5,000 | | |
| 1 | | |
$ | - | | |
| 715,596 | | |
| 715 | |
| |
| - | | |
| - | | |
| 51,820,692 | | |
| - | | |
| (56,207,315 | ) | |
| |
| 1,191,916 | | |
| |
| (46,477 | ) | |
| (3,235,469 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for conversion of convertible debt and accrued interest | |
| - | | |
| - | | |
| - | | |
| - | | |
| 702,623 | | |
| 703 | |
| |
| - | | |
| - | | |
| 141,126 | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| 141,829 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Reversal
of common stock issuable due to cancellation of conversions of convertible debt and accrued interest | |
| - | | |
| - | | |
| - | | |
| - | | |
| (24,427 | ) | |
| (24 | ) |
| |
| - | | |
| - | | |
| (19,992 | ) | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| (20,016 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Reversal
of put premium upon cancellation of conversions of convertible debt | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| - | | |
| - | | |
| (11,785 | ) | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| (11,785 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Reclassification
of put premium upon debt conversion | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| - | | |
| - | | |
| 68,090 | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| 68,090 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Issuance
of common stock for cashless exercise of warrants | |
| - | | |
| - | | |
| - | | |
| - | | |
| 52,900 | | |
| 53 | |
| |
| 147,099 | | |
| 147 | | |
| (200 | ) | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Stock
based compensation in connection with stock option grants | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| - | | |
| - | | |
| 20,718 | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| 20,718 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| |
| | | |
| |
| | | |
| | |
Vested
restricted stock units | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | | |
| - | |
| |
| 59 | | |
| - | | |
| - | | |
| - | | |
| - | | |
| |
| - | | |
| |
| - | | |
| - | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | | |